Email Updates

You are here

Home

21 OCTOBER 2022 VOLUME 24 ISSUE 42

Media Coverage

  • COVID-19 Vaccine and Booster Highly Effective in People With HIV, Large Studies Show

    Two studies published this month provide reassurance that people with HIV who are vaccinated against COVID-19 have a low risk of serious illness or death, and both studies show that a third dose of SARS-CoV-2 vaccine provided even greater protection. The findings come from two large cohort studies. The Corona-Infectious-Virus Epidemiology Team (CIVET-II) study looked at post-vaccination COVID-19 outcomes in people with HIV in the United States who were fully vaccinated by 30 June 2021.

    October 21, 2022
    General
    aidsmap

  • Zimbabwe Becomes First African Nation To Approve HIV Prevention Drug

    Zimbabwe has become the first country in Africa and the third in the world to approve an HIV prevention drug recently recommended by the World Health Organization (WHO). Regulators in Australia and the US have already given their backing to use the long-acting injectable cabotegravir (CAB-LA), and the WHO welcomed the move by Zimbabwe. The country’s fight against HIV has seen AIDS-related deaths fall from an estimated 130,000 in 2002 to 20,000 in 2021.

    October 20, 2022
    PrEP
    The Guardian

  • 1.9 Million People Living With HIV Have Access to Free Treatments —USCDC

    Nigeria Country Director of the United States Centers for Disease Control and Prevention (USCDC), Dr. Mary Boyd has said that about 1.9 million people living with HIV in Nigeria have access to free treatments to save their lives. Boyd made this known at the opening of a 2-day CDC Biannual Program Performance Review Meeting and Symposium yesterday in Abuja with the theme: “Working Together to Bring Nigeria Closer to HIV Epidemic Control”.

    October 20, 2022
    Treatment
    Vanguard

  • Vending Machines for HIV Self Test Mouth Swab Kits Launched in the UK

    Vending machines that dispense free blood-free mouth swab HIV self testing kits have been set up at four locations in the United Kingdom. The vending machines are located at four venues, including at a shopping centre, in Bristol, North Somerset and South Gloucestershire. “We hope that placing these vending machines in public spaces around Bristol, North Somerset and South Gloucestershire will help people access tests. We’re particularly excited to introduce easy, blood-free mouth swab HIV tests for the first time,” said Jo Kesten, ARC West in a statement.

    October 20, 2022
    General
    Star Observer

  • Britain Slashes Foreign Aid: ‘You Couldn’t Pick a Worse Time’

    Britain, among the leading donors to the poorest nations, has slashed its foreign aid contributions, imperiling global progress against infectious diseases, famine and climate change, as well as efforts to improve girls’ education and sexual and reproductive health. Since 2020, the country has cut its human rights work by 80 percent, funds for some global health programs by more than 80 percent and humanitarian aid to Yemen, Syria and other nations by 60 percent.

    October 19, 2022
    General
    The New York Times

  • A Letter to … the HIV That Is in My Bloodstream

    Dear HIV, I’ve been living with you since 1998 – that’s 24 years now. In many ways, you have radically changed me. But funnily enough, in many other ways you have not.These days, you are only one aspect of my identity, of which there are many parts: I’m a fair-skinned, Aboriginal gay man who hails from Nganarunga and Kaurna country in south Australia with Scottish and Finnish heritage.

    October 19, 2022
    General
    Al Jazeera

  • Ending Racism Is Key to Better Science: A Message From Nature’s Guest Editors

    In 1768, the UK Royal Society commissioned a research ship, HMS Endeavour, to sail to Tahiti in time to witness a transit of Venus across the Sun. But, as researchers later discovered, the UK government and the society had an extra purpose for the voyage: the ship’s captain, James Cook, had been given secret instructions to continue onwards in what became Britain’s colonial takeover of Australia and New Zealand. This is not an isolated example of a scientific effort that owes its existence to the racist exploitation of humanity.

    October 19, 2022
    General
    Nature

  • No Age Limit on Medical Male Circumcision, Says GP

    Clement Manyathela spoke to Dr Matome Kganakga, on the right age to perform male circumcision and how to take care of a patient post-surgery. Reasons for male circumcision in South Africa varies between medical and non-medical reasons. It has been medically proven that a circumcised man has reduced risk of urinary tract infections, sexually transmitted diseases (STDs), penile cancer and overall increase in hygiene.

    October 19, 2022
    Voluntary Medical Male Circumcision
    702

  • CDC Awards Emory $8.3 Million for HIV Self-Testing Collab Design, Steps Taken Toward More Accessible Testing for Stigmatized Communities

    The Centers for Disease Control and Prevention (CDC) awarded an Emory University-led project $8.3 million to construct a new HIV self-testing program, TogetherTakeMeHome (TTMH). The project’s goal is to ship 1 million tests across the country, making it the largest nationwide mailed HIV self-test program to date. The project was first developed in 2020 with the organization Building Healthy Communities Online (BHOC).

    October 18, 2022
    General
    The Emory Wheel

  • People Living With HIV Are at Greater Risk for Lung Cancer

    People living with HIV are more likely to develop lung cancer compared with the general population, which may be related to a higher rate of smoking and immune suppression, according to study results published in The Lancet HIV. The good news is that lung cancer among HIV-positive people has declined over time, especially for younger age groups.

    October 18, 2022
    General
    POZ Magazine

  • Research Takes Major Step in Pursuit of HIV Cure

    For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation. So says Dr. Ole Schmeltz Søgaard, Professor of Translational Viral Research at Aarhus University, who is the senior author of an innovative study that has just been published in the journal Nature Medicine.

    October 18, 2022
    Cure
    The Mirage

  • Angela Lansbury Was Also a Pioneering AIDS Advocate

    Legendary actress Angela Lansbury, perhaps best known for her TV character Jessica Fletcher from TV’s Murder, She Wrote, died October 11, 2022. As tributes and obituaries recounted her decades-spanning career in film, television and Broadway, many highlighted an aspect of her eclectic life that fans today may not be aware of: Lansbury was a pioneering and vocal HIV and AIDS advocate.

    October 18, 2022
    General
    POZ Magazine

  • Communities in Africa Twice As Likely To Have HIV When Mines Open Nearby

    When industrial mines open in sub-Saharan Africa, the local population becomes twice as likely to be HIV positive than before the mines opened. Mining operations also increase the likelihood of multiple sex partners by 70 percent, high-risk sex partners by 30 percent, and condomless sex by 70 percent. Additionally, mining communities have 20 percent less knowledge about HIV than non-mining areas. Researchers from the Swiss Tropical and Public Health Institute recently published these findings in the journal AIDS.

    October 18, 2022
    General
    aidsmap

  • Pipeline for New PrEP Drugs Has ‘Exciting’ Options

    Product launches for novel HIV pre-exposure prophylaxis (PrEP) drug formulations are looking promising, a speaker said at the 2022 ACCP Global Conference on Clinical Pharmacy. “There are a lot of options coming down the pipeline for PrEP, so this really excites me,” said Emily Drwiega, PharmD, BCIDP, BCPS, AAHIVP, an infectious diseases/HIV clinical pharmacist at the University of Illinois Health, in Chicago.

    October 17, 2022
    PrEP
    Pharmacy Practice News

  • Many Hispanic People With HIV Experience Health Care Discrimination, Study Finds

    Nearly one in four Hispanic or Latino people with HIV experiences health care discrimination, and it is more often experienced by non-white Hispanic people than by white Hispanic people, according to a study. Researchers found that the most prevalent stigma among Hispanic or Latino people was concerns about sharing their HIV status and the most reported form of discrimination was feeling that a clinician was not listening to them.

    October 17, 2022
    General
    Infectious Disease News

  • Considerations in the Aging Population With HIV

    The treatment of HIV has evolved over the last 40 years to a point where the life expectancies of people with HIV rival those without the disease. Typically, people older than 50 years of age are considered “older adults” or “aging” in the HIV literature.1 In this new reality, the focus is not only on HIV treatment but the comprehensive management of all comorbid conditions. Major comorbidities in this population include cardiovascular disease, hypertension, diabetes mellitus, and malignancy.

    October 17, 2022
    General
    Infectious Disease Special Edition

  • Lanka Sees New Sex Workers After Currency Collapse, Rise in STI, HIV Detections

    Sri Lanka is seeing a rise in sexually transmitted disease detections as inexperienced sex workers enter the profession, health officials say. Traditional high-risk communities including drug users and homosexual persons with multiple partners continue to be factors in the rise of STIs, according to health officials. According to the National STD/AIDS Control Programme, 4,556 HIV patients have been recorded in the first quarter of 2022 up 11.8 percent from 4,073 in 2021 first quarter.

    October 16, 2022
    General
    The Island

  • Potential Cure for HIV from CRISPR Gene Editing in Phase 1/2 Clinical Trial

    A potential cure for human immunodeficiency virus type 1 (HIV-1) created with CRISPR-based editing of HIV proviral DNA was well tolerated by the first participant of a phase 1/2 clinical trial, according to an announcement in September by study sponsor, Excision Biotherapeutics. "It is the first time a CRISPR-based therapy targeting an infectious disease has been administered to a patient, and is expected to enable the first ever clinical assessment of a multiplexed, in vivo gene editing approach," said Daniel Dornbusch, CEO of Excision.

    October 16, 2022
    Cure
    Contagion Live

  • The Men We Lost to AIDS

    Rebecca Makkai’s great believers are those who faced the trauma of the AIDS epidemic in Chicago in the mid-1980s, part of a lost generation of men who were the first to be affected by the deadly disease that decimated the gay community. With gentle honesty, she shows us these men. their lives, and their dreams of love, a family, and a home of their own. They faced the cruelty and stigma of a mysterious disease that brought loss after loss of loved ones, with no hope of a cure.

    October 14, 2022
    General
    Psychology Today

Published Research

Announcements